THE ACTIONS OF BOSENTAN, AN ENDOTHELIN RECEPTOR ANTAGONIST, ON CEREBRAL ARTERIOLES IN-SITU

被引:0
|
作者
PATEL, TR [1 ]
MCAULEY, MA [1 ]
MCCULLOCH, J [1 ]
机构
[1] UNIV GLASGOW,WELLCOME NEUROSCI GRP,GLASGOW G61 1QH,SCOTLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:U31 / U31
页数:1
相关论文
共 50 条
  • [31] Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension
    Halank, M
    Miehlke, S
    Hoeffken, G
    Schmeisser, A
    Schulze, M
    Strasser, RH
    TRANSPLANTATION, 2004, 77 (11) : 1775 - 1776
  • [32] Absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan in healthy male subjects
    Weber, C
    Gasser, R
    Hopfgartner, G
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (07) : 810 - 815
  • [33] 3 ENDOTHELIN RECEPTOR SUBTYPES SUGGESTED BY THE DIFFERENTIAL POTENCY OF BOSENTAN, A NOVEL ENDOTHELIN RECEPTOR ANTAGONIST, IN ISOLATED-TISSUES
    GRAY, GA
    CLOZEL, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U62 - U62
  • [34] The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
    Krum, H
    Viskoper, RJ
    Lacourciere, Y
    Budde, M
    Charlon, V
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12): : 784 - 790
  • [35] Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
    Chen, SJ
    Chen, YF
    Meng, QC
    Durand, J
    Dicarlo, VS
    Oparil, S
    JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (06) : 2122 - 2131
  • [36] Influence of mild liver impairment on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist
    van Giersbergen, PLM
    Popescu, G
    Bodin, F
    Dingemanse, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (01): : 15 - 22
  • [37] Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle
    Herbert, KJ
    Hickey, MJ
    Lepore, DA
    Knight, KR
    Morrison, WA
    Stewart, AG
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (01) : 59 - 67
  • [38] Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (07) : 310 - 316
  • [39] Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice
    Pinho-Ribeiro, Felipe A.
    Borghi, Sergio M.
    Staurengo-Ferrari, Larissa
    Filgueiras, Guilherme B.
    Estanislau, Celio
    Verri, Waldiceu A., Jr.
    NEUROSCIENCE LETTERS, 2014, 560 : 57 - 61
  • [40] Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin
    Dingemanse, J
    Schaarschmidt, D
    van Giersbergen, PLM
    CLINICAL PHARMACOKINETICS, 2003, 42 (03) : 293 - 301